On the 20th of May, the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) announced a funding programme for implementation of a competence and networking platform in the field of Open Access.
Here is some information from the call for proposals…
“With the funding initiative for the competence and networking platform in the area of Open Access, the BMBF is aiming to
- bundle provision and communication of information on Open Access;
- offer training opportunities for audiences from different locations and disciplines;
- improve networking and cooperation between the actors involved from the scientific community.”
“Public and private universities as well as non-university research institutions, scientific institutions and comparable institutions are eligible to apply. (…)
Research institutions that receive basic funding from the Federal Government and/or the federal states can only be granted project funding for their additional project-related expenses or costs under certain conditions in addition to their institutional funding.
The funding of economic activities is excluded.”
Duration and amount of funding:
“A joint project is to be funded over a project duration of up to 36 months by means of full financing. A total of up to 800,000 euros p.a. is available for this purpose (distributed over all sub-projects). (…) The planned start of funding is 1 January 2020.”
For some, this may seem better than the Wiley Deal in Germany: French universities and research institutions have agreed in principle, through their Couperin consortium, to renew their national licence with Elsevier. In a letter sent on April 11 to Elsevier by Lise Dumasy, president of Couperin, details of the agreement, which is valid for 4 years, effective as of January 1 this year, are revealed.
With this agreement, French universities and research institutions will have access to the publisher’s “Freedom complete edition” journal bundle including e.g. The Lancet and Cell Press. However, the consortium does not guarantee to the publisher that all its members will adhere to the national licence.
Here are the main points:
- Most surprising: This agreement provides for a gradual 13.3% reduction in license costs over 4 years -5% in 2019, -4% in 2020, -3% in 2021 and -2% in 2022, in total -13.305% over four years.
- There is 25% discount on article processing charges (APC). There will also be a compensatory clause if these APCs increase by more than 3.5%. Excluded from this discount are – as I understand it – only the society journals, e.g. The Lancet and the Cell Press titles. Included are all Open Access journals and hybrid journals. The 3.5% threshold refers to annual price increases.
- Regarding Green Open Access the agreement allows automatic access 12 months after formal publication to the “accepted author manuscript” (AAM) or post print directly on Elsevier’s service Sciencedirect. After 24 months the pdf file of this manuscript will be deposited on the HAL platform (the CNRS Open Access Repository). The license to make AAMs available is more restrictive than most Creative Commons licenses. It allows reading, downloading, printing, translating, text & data mining but does not allow redistribution or re-use (neither commercial or non-commercial).
Finally, the agreement includes the progressive deposit (from 2020 to 2022) of articles published between 2002 and 2012, which will make it possible to apply text & data mining.
Here you can read the letter sent by the president of the Couperin consortium to Elsevier. I would also like to draw your attention to Martin Clavey’s posting that I have mainly reported here. Information about the Wiley DEAL mentioned at the introduction can be found in Marcel Knöchelmann’s posting on Le Publikateur.